✦ LIBER ✦

W1841 A Model for Defining Molecular Aspects of Pancreatic Ductal Adenocarcinoma Patients for Targeted Adjuvant Therapy

✍ Scribed by Showalter, Shayna L.; Witkiewicz, Agnes; Cozzitorto, Joseph A.; Sauter, Patricia K.; Kennedy, Eugeen P.; Yeo, Charles J.; Brody, Jonathan R.

Book ID: 122465071
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 141 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)64289-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Nomogram for Predicting the Benefit of

A Nomogram for Predicting the Benefit of Adjuvant Therapy for Resected Pancreatic Ductal Adenocarcinoma

✍ Bicquart, C.; El Youssef, R.; Wissel, A.R.; Sheppard, B.C.; Billingsley, K.G.; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

High hENT1 expression is predictive of r

High hENT1 expression is predictive of response of to adjuvant gemcitabine for pancreatic ductal adenocarcinoma patients randomized to adjuvant therapies in the ESPAC trials

✍ Neoptolemos, J.P.; Cox, T.F.; Greenhalf, W.; Garner, L.; Campbell, F.; Ghaneh, P 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 45 KB

Results and patterns of failure in patie

Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma

✍ Jona A. Hattangadi; Theodore S. Hong; Beow Y. Yeap; Harvey J. Mamon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB